Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71826 - 71850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	NF1	4763	upregulated	Silicon Dioxide analog results in increased expression of NF1 mRNA	17q11.2	A24194
Silicon dioxide	Approved	NF1	4763	upregulated	Silicon Dioxide results in increased expression of NF1 mRNA	17q11.2	A24196
Silicon dioxide	Approved	NF2	4771	upregulated	Silicon Dioxide analog results in increased expression of NF2 mRNA	22q12.2	A24195
Silicon dioxide	Approved	NFATC1	4772	downregulated	Silicon Dioxide analog results in decreased expression of NFATC1 mRNA	18q23	A24195
Silicon dioxide	Approved	NFATC1	4772	upregulated	Silicon Dioxide analog results in increased expression of NFATC1 mRNA	18q23	A24194
Silicon dioxide	Approved	NFATC2	4773	upregulated	Silicon Dioxide analog results in increased expression of NFATC2 mRNA	20q13.2	A24194
Silicon dioxide	Approved	NFE2	4778	downregulated	Silicon Dioxide analog results in decreased expression of NFE2 mRNA	12q13	A24195
Silicon dioxide	Approved	NFE2	4778	upregulated	Silicon Dioxide analog results in increased expression of NFE2 mRNA	12q13	A24194
Silicon dioxide	Approved	NFE4	58160	upregulated	Silicon Dioxide analog results in increased expression of NFE4 mRNA	7q22.1	A24194
Silicon dioxide	Approved	NFIA	4774	downregulated	Silicon Dioxide analog results in decreased expression of NFIA mRNA	1p31.3	A24195
Silicon dioxide	Approved	NFIL3	4783	downregulated	Silicon Dioxide analog results in decreased expression of NFIL3 mRNA	9q22.31	A24195
Silicon dioxide	Approved	NFIL3	4783	downregulated	Silicon Dioxide results in decreased expression of NFIL3 mRNA	9q22.31	A24196
Silicon dioxide	Approved	NFIX	4784	upregulated	Silicon Dioxide analog results in increased expression of NFIX mRNA	19p13.13	A24194
Silicon dioxide	Approved	NFKB2	4791	upregulated	Silicon Dioxide analog results in increased expression of NFKB2 mRNA	10q24.32	A24195
Silicon dioxide	Approved	NFKB2	4791	upregulated	Silicon Dioxide results in increased expression of NFKB2 mRNA	10q24.32	A24196
Silicon dioxide	Approved	NFKBIA	4792	upregulated	Silicon Dioxide analog results in increased expression of NFKBIA mRNA	14q13.2	A24195
Silicon dioxide	Approved	NFKBIA	4792	upregulated	Silicon Dioxide results in increased expression of NFKBIA mRNA	14q13.2	A24196
Silicon dioxide	Approved	NFKBID	84807	upregulated	Silicon Dioxide analog results in increased expression of NFKBID mRNA	19q13.12	A24194 A24195
Silicon dioxide	Approved	NFKBIE	4794	upregulated	Silicon Dioxide analog results in increased expression of NFKBIE mRNA	6p21.1	A24195
Silicon dioxide	Approved	NFKBIE	4794	upregulated	Silicon Dioxide results in increased expression of NFKBIE mRNA	6p21.1	A24196
Silicon dioxide	Approved	NFKBIZ	64332	upregulated	Silicon Dioxide analog results in increased expression of NFKBIZ mRNA	3q12.3	A24195
Silicon dioxide	Approved	NHLH2	4808	downregulated	Silicon Dioxide results in decreased expression of NHLH2 mRNA	1p13.1	A24196
Silicon dioxide	Approved	NID2	22795	upregulated	Silicon Dioxide analog results in increased expression of NID2 mRNA	14q22.1	A24195
Silicon dioxide	Approved	NIFK	84365	upregulated	Silicon Dioxide analog results in increased expression of NIFK mRNA	2q14.3	A24195
Silicon dioxide	Approved	NIM1K	167359	downregulated	Silicon Dioxide analog results in decreased expression of NIM1K mRNA	5p12	A24195

Displaying entries 71826 - 71850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability